Optimization of an animal test protocol for toxicogenomics studies (II); a cross-laboratory gene expression analysis

Journal of Toxicological Sciences

Volumn 32, Issue 1, 2007, Pages 33-45

  Sumida, Kayo ^a   Saito, Koichi ^a   Oeda, Kenji ^a   Otsuka, Masanori ^b   Tsujimura, Kazunari ^b   Miyaura, Hideki ^b   Sekijima, Masaru ^c   Nakayama, Koji ^c   Kawano, Yukiko ^c   Kawakami, Yuki ^c   Asamoto, Makoto ^d   Shirai, Tomoyuki ^d  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

^b CHEMICALS EVALUATION AND RESEARCH INSTITUTE   (Japan)

^c MITSUBISHI CHEMICAL CORPORATION   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Gene expression analysis; Optimized animal test protocol; Reproducibility; Toxicogenomics

Indexed keywords

RNA; SAFROLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE PROBE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; LIVER; LIVER CARCINOGENESIS; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; RAT; REPRODUCIBILITY; RNA ANALYSIS; TISSUE MICROARRAY; TOXICOGENETICS; VALIDITY;

ANIMALIA;

ANIMALS; CARCINOGENICITY TESTS; GENE EXPRESSION PROFILING; LABORATORIES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; TOXICOGENETICS;

EID: 33847383272     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.32.33     Document Type: Article

References (19)

1. Baker, V.A., Harries, H.M., Waring, J.F., Duggan, C.M., Ni, H.A., Jolly, R.A., Yoon, L.W., De Souza, A.T., Schmid, J.E., Brown, R.H., Ulrich, R.G. and Rockett, J.C. (2004): Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays. Environ. Health Perspect., 112, 428-438.
2. Bartosiewicz, M.J., Jenkins, D., Penn, S., Emery, J. and Buckpitt, A. (2001): Unique gene expression patterns in liver and kidney associated with exposure to chemical toxicants. J. Pharmacol. Exp. Ther., 297, 895-905.
3. de Longueville, F., Atienzar, F.A., Marcq, L., Dufrane, S., Evrard, S., Wouters, L., Leroux, F., Bertholet, V., Ger in, B., Whomsley, R., Arnould, T., Remacle, J. and Canning, M. (2003): Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol. Sci., 75, 378-392.
4. Fisher, R.A. (1955): Statistical methods and scientific induction. J. R. Stat. Soc., 17, 69-78.
5. Gart, J.J., Chu, K.C. and Tarone, R.E. (1979): Statistical issues in interpretation of chronic bioassay tests for carcinogenicity. J. Natl. Cancer Inst., 62, 957-974.
6. Gad, S.C. and Weil, C.S. (1989): Statistics for toxicologists. In Principles and Methods of Toxicology., pp. 435-483, Raven Press, Ltd., NY.
7. Greaves, P. (1990): Histopathology of Preclinical Toxicity Studies. Interpretation and Relevance in Drug Safety Evaluation., pp.432, Elsevier, Amsterdam.
8. Gopinath, C., Prentice, D.E. and Lewis, D.J. (1987): Atlas of Experimental Toxicological Pathology, Vol. 13, pp. 53, MTP Press, Lancaster.
9. Hamadeh, H.K., Bushel, P.R., Jayadev, S., Martin, K., DiSorbo, O., Sieber, S., Bennett, L., Tennant, R., Stoll, R., Barrett, J.C., Blanchard, K., Paules, R.S. and Afshari, C.A. (2002): Gene expression analysis reveals chemical-specific profiles. Toxicol Sci., 67, 219-231.
10. Ioannides, C., Delaforge, M. and Parke, D.V. (1981): Safrole: Its metabolism, carcinogenicity and interactions with cytochrome P450. Food and Cosmetics Toxicol., 19, 657-666.
11. Jung, J.W., Park, J.S., Hwang, J.W., Kang, K.S., Lee, Y.S., Song, B.S., Lee, G.J., Yeo, C.D., Kang, J.S., Lee, W.S., Jeon, K.S., Um, C.H., Kim, Y.S., Oh, M.J., Youn, J.P., Li, P., Park, J.E. and Hwang, S.Y. (2004): Gene expression analysis of peroxisome proliferators- and phenytoin-induced hepatotoxicity using cDNA microarrays. J. Vet. Med. Sci., 66, 1329-1333.
12. Kramer, J.A., Blomme, E.A., Bunch, R.T., Davila, J.C., Jackson, C.J., Jones, P.F., Kolaja, K.L. and Curtiss, S.W. (2003): Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate. Toxicol Pathol., 31, 417-431.
13. Lockhart, D.J., Dong, H., Byrne, M.C., Follettie, M.T., Gallo, M.V., Chee, M.S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H. and Brown, E.L. (1996): Expression monitoring by hybridization to high-sensity oligonucleotide arrays. Nature Biotechnol., 14, 1675-1680.
14. Miller, E.C., Swanson, A.B., Phillips, D.H., Fletcher, T.L., Liem, A. and Miller, J.A. (1983): Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res., 43, 1124-1134.
15. Natarajan, A.T. and Darroudi, F. (1991): Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens. Mutagenesis, 6, 399-403.
16. Pennie, W., Pettit, S.D., Lord, P.G. (2004): Toxicogenomics in risk assessment: An overview of an HESI collaborative research program. Environ. Health Perspect., 112, 417-419.
17. Swanson, A.B., Chambliss, D.D., Blomquist, J.C., Miller, E.C. and Miller, J.A. (1979): The mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants. Mutat. Res., 60, 143-153.
18. To, L.P., Hunt, T.P. and Andersen, M.E. (1982): Mutagenicity of trans-anethole, estragole, eugenol, and safrole in the Ames Salmonella typhimurium assay. Bull. Environ. Contamination Toxicol., 28, 647-654.
19. Ulrich, R.G., Rockett, J.C., Gibson, G.G. and Pettit, S.D. (2004): Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicantson hepatic gene expression. Environ. Health Perspect., 112, 423-427.